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Abstract: Malignant pleural mesothelioma (MPM) is a rare tumor of the visceral and parietal pleura
that is most commonly associated with occupational exposure to asbestos. Since tumor biology is both
aggressive and highly heterogeneous at histopathological and molecular level, prediction of prognosis and
treatment effect remains challenging. Up to date, the best outcome in primary treatment is achieved by a
multimodality approach that includes chemotherapy, followed by macroscopic complete resection (MCR).
However, due to the morbidity associated with radical surgery and the limited life expectancy, a deliberate
allocation to MCR is crucial. While MCR can be accomplished by extrapleural pneumonectomy (EPP)
or extended pleurectomy and decortication (EPD), the current preferential treatment is EPD due to its
lower morbidity and mortality. The present article describes the surgical perspective of MPM treatment
starting off with correct allocation to MCR by applying a multimodality prognostic score (MMPS),
followed by a step-wise description of the EPD with resection and reconstruction of pericardium and
hemidiaphragm. We highlight the importance of repeated intraoperative biopsies and frozen section of
the chest wall, the diaphragm and the pericardium to allow an accurate intraoperative staging and to
adapt the surgical procedure in case of multifocal infiltration. Additionally, the prevention of possible
pitfalls associated with EPD such as esophageal obstruction by the reconstructed hemidiaphragm or
prolonged hospital stay due to persisting air leak are going to be discussed.
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Introduction
Malignant pleural mesothelioma (MPM) is a rare, but yet 
very aggressive tumor, affecting approximately 2,700 people 
per year in the UK and making up for less than 1% of all 
new cancer cases (1). More than 80% of all MPM cases are 
related to occupational exposure to asbestos with a latency 
period between 30 to 50 years. Although there is a decrease 
in incidence of MPM cases since its prohibition in most 
European countries since the mid/end eighties, MPM is 
expected to become a significant problem in third world 
countries in the next centuries (1). 
According to the literature and our own institutional 
experience, a multimodality approach including neoadjuvant 
chemotherapy with platinum and anti-folate doublet, 
followed by macroscopic complete resection (MCR) offers 
better overall and disease-free survival than chemotherapy/
surgery or no therapy alone (2-5). To date, multimodality 
concepts including surgery are part of the most recent 
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international guidelines (6,7).
Due to the tumor’s anatomical restraint, microscopic 
tumor will eventually be left behind. The aim of a radical 
surgical treatment is to achieve MCR (5,8). 
In the last years there has been a change in the preferred 
surgical approach for MPM, away from extrapleural 
pneumonectomy (EPP) and towards (extended) pleurectomy 
and decortication [(E)PD] (9,10). PD includes the resection 
of the visceral and parietal pleura while preserving the 
underlying lung. In most cases an extended PD (EPD) is 
performed which consists of the additional resection of the 
diaphragm and/or the pericardium. 
In meta-analyses of several retrospective studies it was 
demonstrated that 30-day survival was significantly better 
(up to 2.5-fold) and postoperative complications were less 
frequent in patients undergoing EPD compared to EPP 
(3,11). Furthermore, the available evidence suggest that 
the postoperative quality of life is better after EPD (12). 
Nevertheless, the management of the prolonged air 
leak, which occurs in 90–100% of EPD cases, remains 
a challenge. A propensity-score matched analysis of our 
own data from the past 20 years showed similar rates in 
morbidity and comparable rates of overall survival between 
EPP and EPD, when treated in a multimodality therapy 
concept. However, 90-day mortality rates were lower for 
EPD than for EPP patients (0% for EPD vs. 8% for EPP, 
P=0.3) and the postoperative stay on the intensive care 
unit was significantly longer in patients undergoing EPP 
{3 [1–21] vs. 2 (0–19) days, P=0.001} (13). In consideration 
of this increasing evidence, there is a tendency towards 
EPD in many centers in the past decade (9). 
Patient selection and workup
The patient’s individual treatment plan needs to be 
determined at an interdisciplinary tumor board with 
participating experts in thoracic surgery, medical oncology, 
radiation oncology, pneumology, radiology and pathology (6). 
After induction chemotherapy, a re-staging PET-CT is 
required prior to surgery (Figure 1). A good performance 
status and sufficient functional reserve to perform 
daily activities are essential as eligible candidates for 
surgery. Patient selection remains difficult, since most 
prognosticators are deficient and local recurrence patterns 
are unpredictable even for early-stages (15). However, it 
has been confirmed in clinical models that a number of 
parameters are of predictive and prognostic significance. 
Among those parameters, the histologic subtype is very 
relevant with epithelioid MPM bearing the best overall 
survival. Further parameters for poor survival include 
male sex, age >50 years, anemia, leukocytosis, a high 
serum C-reactive protein (CRP), a high serum lactate 
dehydrogenase (LDH), low serum albumin and a poor 
performance status (16,17). Furthermore, several studies 
showed that the tumor volume at the initial diagnosis 
may predict the outcome after surgery and may correlate 
with the pT/pN stage (18-20). At our institution, a 
multimodality prognostic score (MMPS) was established 
to use as independent prognosticator for a better patient 
selection. This MMP-Score was validated in other centers 
and enables the identification of patients who are likely to 
not benefit from surgery in a multimodality approach (21). 
The MMP-score includes four variables that are routinely 
assessed preoperatively:
Figure 1 PET-CT imaging before and after neoadjuvant chemotherapy. (A) The PET-CT before induction chemotherapy depicts the extent 
of tumor infiltration and helps to identify patients with advanced tumor stages including contralateral pleural or peritoneal involvement; (B) the 
re-staging PET-CT is performed 2 weeks after induction chemotherapy and is assessed according to the modified RECIST criteria (14).
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 Tumor volume before chemotherapy >500 cm3;
 Non-epithelioid histological subtype;
 Initial CRP-value >30 mg/L (before chemotherapy);
 Progressive disease after chemotherapy [assessed 
in the re-staging PET-CT according to modified 
RECIST criteria (14)].
In patients with a MMPS of three or four, surgery 
with radical intent does not prolong overall survival when 
compared to untreated patients. In consideration of these 
findings, a multimodality approach including MCR is 
only performed in patients with a MMP-Score of two or 
smaller. In general surgery is planned within four to six 
weeks after the last cycle of induction chemotherapy to 
ensure a recovery phase for the patient after induction 
chemotherapy. 
Pre-operative preparation
Prior to the operation, a full physical examination is carried 
out and standard laboratory tests are performed in our 
outpatient clinic. After induction chemotherapy, mild 
anemia is very common in patients presenting for radical 
surgery. Due to the inherent risk of increased perioperative 
blood loss, patients with anemia are preoperatively treated 
according to our protocol for patient blood management in 
order to minimize rates of blood transfusions. In patients 
with preoperative iron deficiency anemia, treatment consists 
of 1,000 mg iron-carboxymaltose intravenously and 40,000 
IU erythropoietin alpha subcutaneously (22).
In all patients, regardless whether an EPP or an EPD is 
intended, the postoperative lung capacity is preoperatively 
estimated by lung function test and a ventilation/perfusion 
(V/Q) scan in order to estimate the possible extent of the 
operation up to a pneumonectomy in cases, where the tumor 
infiltrates the lung parenchyma with such an extent that no 
preservation of the underlying lung parenchyma is possible 
and EPP is justified. One of the reasons is that the lung 
does not account as functional anymore. For cardiologic 
risk stratification, the recalibrated thoracic revised cardiac 
risk index (RCRI) is applied (23). In patients at risk for 
cardiovascular disease, further examinations are performed 
according to the ESC/ESA guidelines on non-cardiac 
surgery (24). A chest magnetic resonance imaging (MRI) can 
help to identify tumor infiltration into surrounding structures 
especially in the chest wall (endothoracic fascia, intercostal 
musculature or ribs), diaphragm or pericardium (25). 
Equipment
 Rib retractor
 Spatula for decortication
 Gore-Tex® Dualmesh® biomaterial patch (2 mm) for 
the reconstruction of the hemidiaphragm (W.L. Gore 
& Associates Inc., Flagstaff, AZ, USA)
 Acellular, biological patch for pericardial reconstruction 
(PeriGuard®, Lamed, Germany)
 PleurX® drainage system for home use.
Procedure
Apart from the lateral thoracotomy, the first steps of 
the parietal pleurectomy are performed in double-
lung ventilation to facilitate the extrapleural separation 
of the parietal pleura. Isolation of the affected lung is 
achieved thereafter via the double-lumen endotracheal 
tube. Intravenous antibiotic prophylaxis with amoxicillin/
clavulanic acid is administered at least 30 minutes prior to 
surgery. The patient is placed in lateral position and the 
table is buckled underneath the thorax in order to open the 
intercostal space.
Extended lateral thoracotomy (Figure 2)
A skin incision on the level of the 6th rib for an extended 
lateral thoracotomy is performed. The latissimus muscle 
is mobilized anteriorly and if possible dorsally retracted 
without cutting it. The serratus anterior muscle is divided 
above the 6th rib. After incision of the periosteum, a 
periosteal elevator helps to shift it off the inferior angle 
of the 6th rib. The 6th intercostal space is then entered 
extrapleurally and a ventral excision of the costal arch is 
Figure 2 Extended lateral thoracotomy (26). 
Available online: http://www.asvide.com/watch/33079
Video 1. Extended lateral thoracotomy
Raphael S. Werner, Claudio Caviezel, Olivia Lauk, 
Isabelle Opitz*
Department of Thoracic Surgery, University 
Hospital Zurich, Zurich, Switzerland
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performed. This maneuver enables an extended exposure of 
the situs, making it possible to perform the whole operation 
without an additional utility thoracotomy. Furthermore, the 
partial chondrectomy facilitates the intercostal closure at 
the end of the operation. Routinely former trocar sites are 
excised through all layers of the chest wall and removed in a 
single piece. 
Dissection of the parietal pleura (Figure 3)
Using blunt force with swab sticks or the finger tips, the 
membrane between the thickened parietal pleura and the 
endothoracic fascia is first dissected in ventral direction and 
towards the apex. 
During the procedure, biopsies of the pericardium 
and the chest wall, as well as any lesion with suspicion of 
infiltrating character should be taken for frozen section. In 
case of microscopic infiltration, further resection is required 
if feasible. In cases where multilevel chest wall infiltration 
is proven, a partial pleurectomy without decortication 
of the visceral pleura is a reasonable alternative to EPD 
in our opinion. In anterior and apical direction, the 
internal mammary artery and the subclavian vessels need 
to be located and preserved. For secure hemostasis, we 
recommend sharp preparation and double-clipping of 
the side branches of the internal mammarian vessels. The 
dissection is further proceeded towards the mediastinum. 
While on the right side, the superior vena cava and the 
azygous vein need to be approached with caution, on the left 
side, precaution is warranted for the aortic arch its vessels 
and the descending aorta. If possible, the phrenic nerve 
and, in particular, the recurrent laryngeal nerve should 
be preserved, especially in patients with low tumor load 
and the possibility to preserve the diaphragm. The patient 
will profit postoperatively due to increased respiratory 
function. After dissection of the hilar structures, the pleura 
is separated from the esophagus. A large nasogastric 
tube should routinely be placed and helps to palpate the 
esophagus and distinguish it from surrounding tissue. If 
macroscopic or microscopic (confirmed by frozen section) 
infiltration of the pericardium is present, the pericardium is 
resected as well.
Subsequently, the costophrenic sinus is dissected and 
the parietal pleura is removed from the diaphragm. In 
case of macroscopic or microscopic infiltration, resection 
of the diaphragm is indicated. By using swab sticks, the 
diaphragm is retracted and dissected from the peritoneum. 
If peritoneal lesions become apparent, biopsies should be 
taken for frozen section and the peritoneal cavity should 
be endoscopically visualized in order to exclude further 
peritoneal dissemination.
Decortication of the visceral pleura (Figure 4)
After pleurectomy of the parietal pleura, the pleural 
cap encasing the lung is opened and an incision is 
made superficially into the visceral pleura of each lobe. 
Decortication is performed on a ventilated ipsilateral 
lung with a positive end-expiratory pressure (PEEP) of 
5–10 mmHg. Starting from the incision, the visceral pleura 
is dissected from the lung parenchyma via blunt dissection 
or with small swab sticks. The complete removal of any 
anthracotic pigment on the lung surface helps to identify 
and confirm that the right layer of visceral pleura is being 
dissected. The visceral pleura is peeled off towards the 
Figure 3 Dissection of the parietal pleura, resection of the 
hemidiaphragm and the pericardium (27). 
Available online: http://www.asvide.com/watch/33080
Figure 4 Decortication of the visceral pleura (28). 
Available online: http://www.asvide.com/watch/33081
Video 2. Dissection of the parietal pleura, 
resection of the hemidiaphragm and the 
pericardium
Raphael S. Werner, Claudio Caviezel, Olivia Lauk, 
Isabelle Opitz*
Department of Thoracic Surgery, University 
Hospital Zurich, Zurich, Switzerland
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Video 3. Decortication of the visceral pleura
Raphael S. Werner, Claudio Caviezel, Olivia Lauk, 
Isabelle Opitz*
Department of Thoracic Surgery, University 
Hospital Zurich, Zurich, Switzerland
▲
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apex and the basis of every lobe, followed by interlobar 
dissection towards the hilus. Especially the dissection along 
the fissures is challenging. If possible, the tumor tissue is 
removed in a single piece containing visceral and parietal 
pleura, as well as the resected diaphragm and pericardium. 
In case of infiltration of the lung parenchyma, single wedge-
resections might be necessary. The decortication of the 
lobes’ atelectatic edges can be similarly challenging and also 
here, wedge-resections can facilitate the procedure. 
Reconstruction of the pericardium and the hemidiaphragm 
(Figure 5)
For reconstruction of the diaphragm, a Gore-Tex® 
Dualmesh® biomaterial patch (W.L. Gore & Associates 
Inc., Flagstaff, AZ, USA) is put in place and fixed at the 
chest wall with a 1-0 Prolene® suture loop. The Gore-Tex® 
Patch is oriented with the rough CORDUROY® surface 
facing the lung to enhance adhesions and minimize residual 
pleural space. Sutures should be placed around the adjacent 
ribs to provide additional fixation. In order to compensate 
for the smaller residual lung after decortication, we attach 
the patch almost horizontally and more cranial than the 
diaphragm’s original position and fix it directly around the 
rib below the thoracotomy. By minimizing the pleural space, 
it is intended to reduce the subsequent seropneumothorax 
and the coherent risk of pleural infections. On the left side, 
a gap as large as about a fingertip needs to be left towards 
the esophagus to avoid subsequent anatomical or functional 
obstruction by the Gore-Tex® patch and to avoid gastric 
herniation. Towards the entry of the inferior vena cava and 
the esophagus, additional point sutures are used to attach 
the Gore-Tex® patch. 
The resected pericardium is reconstructed with an 
acellular biological patch. In order to avoid cardiac 
herniation and to allow an evacuation of accumulating fluid, 
the pericardial sac should be loosely closed and a small gap 
should be left open towards its top.
Lymphadenectomy
We recommend systematic lymphadenectomy of the 
mediastinal lymph nodes according to lung cancer surgery 
(right side: ATS 2R, 4R, 7, 10R; left side: ATS 5, 6, 7, 
10L) and the internal mammary and intercostal nodes if 
applicable. 
Hemostasis and closure of the thoracotomy
After obtaining hemostasis by argon beaming and irrigation 
with povidone-iodine diluted saline solution, three chest 
tubes should be placed in anteroapical, posteroapical 
and basal direction. At our center, a PleurX® drainage 
system (Becton Dickinson, Franklin Lakes, NJ, USA) is 
used instead of a third chest tube in cases where visceral 
decortication was performed. With a high incidence of 
prolonged air-leak in these patients, this indwelling catheter 
system may reduce the duration of hospital stay by enabling 
easy and safe home-usage. The thoracotomy is closed with 
a loop suture, followed by re-adaptation of the serratus 
anterior muscle, subcutaneous and intracutaneous suture.
Tips, tricks and pitfalls
 High intraoperative FiO2 and/or barotrauma after 
induction chemotherapy can tr igger an acute 
respiratory distress syndrome (ARDS). It has been 
shown in previous analyses, that centers with a low 
volume of EPPs have a significantly higher incidence in 
ARDS. Therefore, the center’s EPD case volume and 
its capability to handle a potential ARDS by offering 
support through extracorporal membrane oxygenation 
(ECMO) significantly influences morbidity and 
mortality in MPM surgery (30).
 During the dissection of the parietal pleura, biopsies 
of the endothoracic fascia and its underlying tissue, 
the diaphragm and the pericardium should be taken. 
Frozen section is used to exclude multilevel chest wall 
infiltration. In case of multifocal chest wall infiltrations, 
an isolated parietal pleurectomy without decortication 
Figure 5  Reconstruct ion  of  the  per icard ium and the 
hemidiaphragm (29). 
Available online: http://www.asvide.com/watch/33082
Video 4. Reconstruction of the pericardium 
and the hemidiaphragm
Raphael S. Werner, Claudio Caviezel, Olivia Lauk, 
Isabelle Opitz*
Department of Thoracic Surgery, University 
Hospital Zurich, Zurich, Switzerland
▲
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of the visceral pleura is in our opinion a reasonable 
alternative to a complete macroscopic resection. 
 During the resection of the right hemidiaphragm and 
during patch reconstruction, careful dissection around 
the inferior vena cava is important at the diaphragm’s 
caval hiatus. 
 Due to the extent of the tumor, the esophagus can 
be difficult to identify. Therefore, we generally 
recommend to place a large nasogastric tube that helps 
to palpate the esophagus and distinguish it from the 
surrounding tissue. 
 In patients with multifocal tumor infiltration in the 
lung parenchyma with severely compromised perfusion 
(V/Q-scan) of the diseased lung, single wedge resections 
may not be sufficient in order to achieve MCR. In such 
cases, an intraoperative strategical switch to EPP may 
be justified, of course given that the remaining lung 
offers sufficient quality and functional reserve.
 We recommend the reconstruction of the resected 
diaphragm in order to prevent gastric herniation. Since 
the Gore-Tex® Dualmesh® patch is inelastic, increased 
tension on the patch results in increased tension on 
its anchorage. On the left side, a small gap sizing 
about a fingertip between the anchoring suture and 
the esophagus may avoid shear force and subsequent 
anatomical or functional obstruction of the esophagus.
 While the textured CORDUROY® surface of the 
Gore-Tex® Dualmesh® patch encourages host tissue 
incorporation, the other surface prevents tissue 
attachment. In order to minimize the residual pleural 
space by increasing the decorticated lung’s adhesion to 
the neo-diaphragm, we place the CORDUROY surface 
facing the lung parenchyma.
 Due to the high rates of prolonged air-leak (in up 
to 90–100% of all patients), insertion of a PleurX® 
drainage system instead of the third chest tube can be 
considered. This procedure enables a simple and safe 
home-usage to deal with the air leak and may reduce 
the duration of hospital stay.
Conclusions
Current guidelines recommend a multimodality treatment 
including induction chemotherapy followed by MCR for a 
selected group of patients. At our center we overlook more 
than 20 years of experience with a multimodality approach 
including MCR. The precise patient selection within 
an interdisciplinary team is essential to offer an optimal 
treatment plan. Due to lower mortality and morbidity rates 
presuming a better quality of life postoperatively, EPD 
should be the preferred surgical approach if feasible. 
Intraoperative biopsies of suspicious infiltrations of 
the chest wall, the diaphragm and the pericardium are 
essential to determine the extent of resection. In case of an 
intraoperatively confirmed multifocal chest wall infiltration, 
a partial pleurectomy without decortication of the visceral 
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